Torrent Pharmaceuticals Limited

NSEI:TORNTPHARM Stock Report

Market Cap: ₹1.2t

Torrent Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Samir Mehta

Chief executive officer

₹260.0m

Total compensation

CEO salary percentage0.02%
CEO tenure36yrs
CEO ownership0.0002%
Management average tenure2.4yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

If EPS Growth Is Important To You, Torrent Pharmaceuticals (NSE:TORNTPHARM) Presents An Opportunity

Dec 16
If EPS Growth Is Important To You, Torrent Pharmaceuticals (NSE:TORNTPHARM) Presents An Opportunity

Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Oct 29
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Oct 24
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Jul 26
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Apr 16
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 03
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Feb 05
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Jan 07
Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

CEO Compensation Analysis

How has Samir Mehta's remuneration changed compared to Torrent Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹18b

Jun 30 2024n/an/a

₹17b

Mar 31 2024₹260m₹40k

₹17b

Dec 31 2023n/an/a

₹15b

Sep 30 2023n/an/a

₹13b

Jun 30 2023n/an/a

₹13b

Mar 31 2023₹230m₹40k

₹12b

Dec 31 2022n/an/a

₹8b

Sep 30 2022n/an/a

₹8b

Jun 30 2022n/an/a

₹8b

Mar 31 2022₹200m₹40k

₹8b

Dec 31 2021n/an/a

₹12b

Sep 30 2021n/an/a

₹13b

Jun 30 2021n/an/a

₹13b

Mar 31 2021₹200m₹40k

₹13b

Dec 31 2020n/an/a

₹12b

Sep 30 2020n/an/a

₹12b

Jun 30 2020n/an/a

₹11b

Mar 31 2020₹200m₹40k

₹10b

Dec 31 2019n/an/a

₹6b

Sep 30 2019n/an/a

₹6b

Jun 30 2019n/an/a

₹5b

Mar 31 2019₹150m₹40k

₹4b

Dec 31 2018n/an/a

₹8b

Sep 30 2018n/an/a

₹6b

Jun 30 2018n/an/a

₹7b

Mar 31 2018₹150m₹40k

₹7b

Compensation vs Market: Samir's total compensation ($USD3.03M) is above average for companies of similar size in the Indian market ($USD1.00M).

Compensation vs Earnings: Samir's compensation has been consistent with company performance over the past year.

CEO

Samir Mehta (61 yo)

36yrs

Tenure

₹260,040,000

Compensation

Mr. Samir Uttamlal Mehta, B.Com., MBA serves as a Managing Director of Torrent Pharmaceuticals Limited since 1989. Mr. Mehta served as Managing Director of Torrent Power Limited. Mr. Mehta has been associa...

Leadership Team

NamePositionTenureCompensationOwnership
Samir Mehta
Executive Chairman & MDno data₹260.04m0.00024%
₹ 2.8m
Aman Mehta
Whole-Time Director2.4yrs₹65.88m0.000060%
₹ 690.4k
Sudhir Menon
Chief Financial Officer6.3yrs₹16.30mno data
Chintan Trivedi
Company Secretary & Compliance Officer2.4yrsno datano data
Jaydip Bhatt
Vice President of Human Resourceno data₹6.56mno data
Ashish Hajarnish
Executive Directorless than a year₹8.25mno data
Abdullah Said Al Abri
Chief Customer Service Officer3.6yrsno datano data
Sanjay Gupta
President and CEO of Torrent Pharma USAno datano datano data

2.4yrs

Average Tenure

58.5yo

Average Age

Experienced Management: TORNTPHARM's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Samir Mehta
Executive Chairman & MD36yrs₹260.04m0.00024%
₹ 2.8m
Aman Mehta
Whole-Time Director2.4yrs₹65.88m0.000060%
₹ 690.4k
Ashish Hajarnish
Executive Directorless than a year₹8.25mno data
Sudhir Mehta
Chairman Emeritus10.5yrsno data0.00030%
₹ 3.5m
Nikhil Khattau
Independent Director1.3yrs₹2.60mno data
Manish Choksi
Independent Director2.5yrs₹4.30mno data
Ameera Shah
Independent Director6.4yrs₹4.90m0.00050%
₹ 5.8m
Nayantara Bali
Independent Director5.8yrs₹6.70mno data
Jinal Mehta
Non-Executive Directorless than a yearno datano data
Maurice Chagnaud
Independent Director2.7yrs₹6.30mno data

2.6yrs

Average Tenure

58yo

Average Age

Experienced Board: TORNTPHARM's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 13:10
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Torrent Pharmaceuticals Limited is covered by 60 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
null nullAntique Stockbroking Ltd.
Meeta ShettyAsian Markets Securities Private Limited